Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:34 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 87 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Obsessive-Compulsive Symptoms Clear all

Conditions: Emotional Regulation, Depression, Anxiety, Borderline Personality Disorder, Obsessive-Compulsive Disorder, Posttraumatic Stress Disorder, Eating Disorders
Interventions: Checking the Facts, Opposite to Emotion Action, Mindfulness of Current Emotions; Behavioral
Lead sponsor: Matthew Southward, PhD; Other
Eligibility: 18 Years and older
Enrollment: 390 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: OCD
Interventions: escitalopram, Placebo ( sugar pill); Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Obsessive-Compulsive Disorder (OCD)
Interventions: Moderate-Intensity Exercise, Low-Intensity Exercise; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 64 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Obsessive-Compulsive Disorder, Illness Anxiety Disorder, Body Dysmorphic Disorders, Somatic Symptom Disorder
Interventions: Fluoxetine, Dextromethorphan; Drug
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Obsessive-compulsive Disorders and Symptoms
Interventions: ACT-Focused ERP, TAU-ERP; Behavioral
Lead sponsor: Mclean Hospital; Other
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2019
U.S. locations: 1
States / cities: Belmont, Massachusetts

Conditions: Trichotillomania, Skin-Picking
Interventions: Dronabinol, Placebo; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Obsessive Compulsive Disorder, Trichotillomania
Interventions: Response inhibition training, Placebo Control Training; Behavioral
Lead sponsor: University of Wisconsin, Milwaukee; Other
Eligibility: 18 Years to 60 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Hoarding Disorder
Interventions: Group Cognitive Behavioral Therapy, Peer Facilitated Support Group; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 323 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Depression, Anxiety, Obsessive Compulsive Disorder (OCD)
Interventions: ATTN201 head-worn focused ultrasound; Device
Lead sponsor: Attune Neurosciences Inc; Industry
Eligibility: 22 Years to 80 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Obsessive-Compulsive Disorder
Interventions: Ketamine, Naltrexone Pill, Placebo pill; Drug · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Stanford, California

Conditions: Obsessive-Compulsive Disorder
Interventions: Celecoxib; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 55 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: New York, New York

Conditions: Patient Diagnosed With OCD and Resistant to SSRI Treatment, Failed SSRI Over 12 Weeks at Appropriate Doses
Interventions: AFQ056, Placebo; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 3
States / cities: San Diego, California • Watertown, Massachusetts • Brooklyn, New York

Conditions: Obsessive-compulsive Disorders and Symptoms, Obsessive-Compulsive Disorder
Interventions: BIXINK OC Free; Device
Lead sponsor: BIXINK Therapeutics Co., Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Hoarding Disorder
Interventions: Imaginal Exposure Writing, Neutral Writing; Behavioral · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Obsessive-Compulsive Symptoms, Cognitive Control
Interventions: Cognitive Control Training; Device
Lead sponsor: Columbia University; Other
Eligibility: 8 Years to 12 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: New York, New York

Conditions: Obsessive-Compulsive Disorder, Generalized Anxiety Disorder, Major Depressive Disorder
Interventions: Emotion Regulation Therapy - Attention Regulation (AR-ERT), Supportive Psychotherapy (SPT); Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 60 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hoarding Disorder, Hoarding, Clutter
Interventions: Facilitated group therapy with behavioral practice; 16 weeks; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 56 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Stanford, California

Conditions: Obsessive Compulsive Disorder
Interventions: Cognitive Behavioral Therapy; Behavioral
Lead sponsor: Hartford Hospital; Other
Eligibility: 20 Years to 60 Years
Enrollment: 128 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Anorexia Nervosa
Interventions: Repetitive Transcranial Magnetic Stimulation (rTMS); Device
Lead sponsor: University of California, San Francisco; Other
Eligibility: 16 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Dystonia, Epilepsy in Children, Cerebral Palsy, Tourette Syndrome, Obsessive-Compulsive Disorder, Neurologic Disorder, Movement Disorders in Children, Movement Disorders, Deep Brain Stimulation
Interventions: Not listed
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 0 Years to 18 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Obsessive-Compulsive Disorder, Pain, Intractable, Depression
Interventions: fMRI and DTI, Behavioral questionnaires, Disease-Specific Patient-Reported Outcomes, Behavioral tests; Diagnostic Test · Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Parkinson's Disease, Essential Tremor, Dystonia, Obsessive Compulsive Disorder
Interventions: Not listed
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 18 Years to 80 Years
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2025
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Tourette Syndrome, Obsessive-Compulsive Disorder, Sensory Disorders
Interventions: None - observational study; Other
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Prader Willi Syndrome, Obsessive-compulsive Disorder
Interventions: Cognitive-behavioral therapy, Wait-list control; Behavioral
Lead sponsor: University of South Florida; Other
Eligibility: 6 Years to 17 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: St. Petersburg, Florida

Search by objective public record fields.

A Precision Medicine Approach to Target Engagement for Emotion Regulation

Pilot Study to Evaluate Escitalopram in Obsessive-compulsive Disorder

Aerobic Exercise and Obsessive-Compulsive Disorder Symptoms

Study of Dextromethorphan in OCD and Related Disorders

Assessing Models of Exposure Therapy

Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors

Developing Effective Response Inhibition Training for Symptom Relief in OCD and Trichotillomania

Comparison of Treatment for Hoarding Disorder

Focused Ultrasound for Behavioral Health

Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)

Neuroinflammation in Patients With OCD

Study to Evaluate the Effect of AFQ056 in Obsessive Compulsive Disorder (OCD) Patients Resistant to Selective Serotonin Reuptake Inhibitor (SSRI) Therapy

An ERP-based Mobile Intervention as an Adjunctive Treatment for OCD

Imaginal Exposure for Hoarding Disorder

Brain Function and Cognitive Control Training in Children With Obsessive-Compulsive Symptoms

Improving Attentional and Cognitive Control in the Psychological Treatment of Intrusive Thoughts

Hoarding Disorder Treatment With Virtual Reality

Neural Mechanisms of CBT Response in Hoarding Disorder

Identifying Networks Underlying Compulsivity in Anorexia Nervosa for Targeting With Neuromodulation

A Multicenter Pediatric Deep Brain Stimulation Registry

Psychosocial, Behavioral, and Radiologic Changes Following Radiosurgery for Benign Neurologic Disease

Sensory Gating Measured With Microelectrode Recording (MER) During Deep Brain Stimulation (DBS) Surgery

Sensory Symptoms in Tourette Syndrome and Obsessive-Compulsive Disorder

Behavioral Treatment of Obsessive-Compulsive Symptoms in Youth With Prader-Willi Syndrome: A Pilot Project